Science and Technology
Creating unique manufacturing technology that allows for unprecedented high throughput cell sorting
OrcaSort™ Technology: Unprecedented high throughput and high purity cell sorting
Conventional cell sorting technology, such as Fluorescence Activated Cell Sorting (FACS) and microfluidics is limited in throughput and scalability which prevents it from being used in advanced clinical settings. Orca Bio has developed OrcaSort™ technology to overcome the limitations of current cell purification methods. OrcaSort™ technology enables unprecedented high throughput sterile manufacturing of cell therapies while achieving over 99% purity.
The technology can be put to broad use and has been extensively tested for its isolation and purification of stem cells and immune cells used in hematopoietic cell grafts.
The components of the technology are optimized for performance and designed to fit seamlessly into the clinical processing of current apheresis products collected from patients.
To avoid patient contamination all components that touch the biological sample are disposable. They are also hermetically sealed to protect the equipment operator.